Topics

No More ‘Major’ Deals For GSK Consumer Before IPO – CEO Walmsley

01:29 EST 15 Jan 2020 | SCRIP

GSK's CEO Emma Walmsley has effectively ruled out further big deals at its Consumer Healthcare unit before the business is...

      

Related Stories

 

Original Article: No More ‘Major’ Deals For GSK Consumer Before IPO – CEO Walmsley

NEXT ARTICLE

More From BioPortfolio on "No More ‘Major’ Deals For GSK Consumer Before IPO – CEO Walmsley"

Quick Search

Relevant Topics

GlaxoSmithKline
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...